Navigation Links
Novel 4-drug combination proves safe for lung cancer treatment
Date:11/13/2008

CHICAGO - The four drug-combination of carboplatin and paclitaxel, with the targeted therapies bevacizumab (Avastin) and cetuximab (Erbitux), is safe and may improve survival for patients with advanced lung cancer, according to a cooperative group study led by The University of Texas M. D. Anderson Cancer Center.

Presented today on the press program of the 2008 Chicago Multidisciplinary Symposium in Thoracic Oncology, sponsored by ASTRO, ASCO, IASLC and the University of Chicago, the study is the first to investigate in lung cancer a four-drug regimen of two standard chemotherapies and targeted therapies.

The Southwest Oncology Group (SWOG) Phase II study was led by Edward S. Kim, M.D., assistant professor in M. D. Anderson's Department of Thoracic Head and Neck Medical Oncology. Until now, the SWOG standard regimen for lung cancer has been carboplatin, paclitaxel and Erbitux, explained Kim; with the addition of Avastin, this study looked to increase efficacy without compromising safety.

"We could not conduct a study with four chemotherapeutic agents in patients due to toxicity concerns," said Kim, the study's principal investigator. "The rationale behind the study was the finding that Avastin enhances the efficacy of existing therapy, thereby possibly improving the carboplatin-paclitaxel-Erbitux regimen."

Data in lung cancer has also suggested there's a "synergistic effect" of pairing the epidermal growth factor (EGFR) inhibitor compounds with the vascular endothelial growth factor (VEGF) inhibitor, explained Kim.

Interestingly, explained Kim, the SWOG's study came at a crossroads for lung cancer - soon after a study was presented showing the benefits of adding Avastin to standard chemotherapy, and prior to a study showing a modest survival benefit when Erbitux is combined with chemotherapy.

Between August 2006 and September 2007, the large Phase II study enrolled 110 Stage IIIB or IV non-small cell lung c
'/>"/>

Contact: Laura Sussman
lsussman@mdanderson.org
713-745-2457
University of Texas M. D. Anderson Cancer Center
Source:Eurekalert

0

GOOD

Page: 1 2

Related medicine news :

1. Novel 3-D cell culture model shows selective tumour uptake of nanoparticles
2. Novel virus detection identifies new viruses in study of respiratory infections and asthma attacks
3. Researchers uncover novel mechanism that balances the sizes of functional areas in the brain
4. Novel Cooling Therapy May Have Aided Injured Football Player
5. ECLIPSE data on effects of Otsukas investigational novel treatment, Tolvaptan
6. SNM seeks novel approaches to molecular imaging to showcase at annual meeting
7. GrantAdler Shipping Novel Implantable Vascular Access Port
8. SNM seeks novel approaches to molecular imaging to showcase at annual meeting
9. Novel strategy under study for aggressive leukemia
10. ISTO Technologies Receives 510(k) Clearance for a Novel Bone Graft Substitute and Bone Graft Extender
11. 454 Sequencing(TM): Science Paper Describes a Novel, Highly Efficient Method of Sequencing Ancient DNA; Sequences the Mitochondria of 10 Individual Mammoths to Prove It
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)PALO ALTO, Calif., Dec. 4 Varian Medical Systems (NYSE: VAR ) announced today that its Board of Directors has set the regular 2010 Annual Meeting of Stockholders for February 11, 2010 with a record
(Date:12/4/2009)SAN FRANCISCO, Dec. 4 Medithrive, Inc. has won the Patient,s Choice Award as the favorite dispensary in the SF Bay Area by popular vote conducted by the online website, www.weedmaps.com. Despite on
(Date:12/4/2009)SCOTTSDALE, Ariz., Dec. 4 Healthcare Trust of America, Inc. ("HTA"), a self-managed, non-traded, real estate investment trust, announced the execution of a purchase and sale agreement to acquire a th
(Date:12/4/2009)ANAHEIM, Calif., Dec. 4 Pamela Bowen, Chief Information Officer at Crescent Healthcare, was selected as a finalist for the "Chief Innovation Officer" Appy Award for transforming Crescent,s business w
(Date:12/4/2009)Late recurrence is a risk for some pediatric cancers, particularly Ewing sarcomas and tumors of the central nervous system, according to a new study published online December 4 in the Journal of the
Breaking Medicine News(10 mins):Health News:Varian Medical Systems Schedules Annual Stockholder Meeting in Palo Alto 2Health News:Healthcare Trust of America, Inc. Executes Agreement to Acquire a 92,500 Square Foot Medical Office Portfolio Located in Texas and Indiana 2Health News:Crescent CIO '09 Dreamforce Conference Speaker and Award Finalist 2
... levels of two proteins in the blood of the patien...rmining the risk of dementia in patients suffering...of one amyloid protein and decreased levels of ano...lity of using these markers in the dementia blood ...
...ents interact and communicate with others, finds a...General Hospital studied the benefits of dolls aft...rom her son, reported the online edition of BBC Ne...d interacted better with staff and other residents...
...exotic particles called solitons.Since the 1980s, ...lectrical charge when traveling through certain //...litons have intricate internal structures. Sc...r of materials science and engineering at Ohio Sta...
...ty hospital's inability to activate emergency powe...iddle of a cataract surgery was awarded over Rs on... "It had taken about 15-20 minutes of crucial...l," observed the Consumer Disputes Redressal Forum...
...e, spread of infectious disease and food security ...ery in order to acquire the proper balance between...aphy professor of Kansas State University has used...din uses remote sensing, in combination with other...
... Toronto General Hospital, researchers have discov...tion //of specific repair cells from the bone marr...ile it has long been known that bone marrow cells ...t stem cells in repairing a damaged heart, restori...
Other Medicine News:Health News:Solitons Could Power Molecular Electronics, Artificial Muscles 2Health News:Solitons Could Power Molecular Electronics, Artificial Muscles 3Health News:Ecological Changes affects human health, food security 2Health News:Bone Marrow Cells Aid In Heart Repair 2Health News:Bone Marrow Cells Aid In Heart Repair 3
(Date:12/4/2009)BETHESDA, Md., Dec. 4 Northwest Biotherapeutics, Inc. ("NWBT" or the "Company") (OTC Bulletin Board: NWBO) announced today that the US Patent and Trademark Office has allowed its patent application o
(Date:12/4/2009)RARITAN, N.J., Dec. 4 Depression, anxiety disorder, bipolar disorder, Attention Deficit Hyperactivity Disorder (ADHD), sleep disorder and migraine: These are among the comorbidities reported to occur
(Date:12/3/2009)ACTON, Mass., Dec. 3 Allen Medical Systems, a subsidiary of Hill-Rom Holdings, Inc. (NYSE: HRC ), today announced the launch of its new Allen Amatech(TM) OEM (Original Equipment Manufacturer) busin
Breaking Medicine Technology:Northwest Biotherapeutics Receives Approval of US Patent for Cost Saving Automation of High-Concentration DCVax(R) Manufacturing 2Northwest Biotherapeutics Receives Approval of US Patent for Cost Saving Automation of High-Concentration DCVax(R) Manufacturing 3Northwest Biotherapeutics Receives Approval of US Patent for Cost Saving Automation of High-Concentration DCVax(R) Manufacturing 4Northwest Biotherapeutics Receives Approval of US Patent for Cost Saving Automation of High-Concentration DCVax(R) Manufacturing 5Looking Ahead to AES 2009: New Insights on Comorbidities and Other Considerations for Epilepsy Treatment 2Looking Ahead to AES 2009: New Insights on Comorbidities and Other Considerations for Epilepsy Treatment 3Allen Medical Systems Announces the Launch of New Allen Amatech(TM) OEM Website 2Early Bedtime May Help Stave Off Teen Depression 48337 1Early Bedtime May Help Stave Off Teen Depression 48337 2Early Bedtime May Help Stave Off Teen Depression 48337 3Elder Care Expert Doctor Marion Receives Accolades from Lehman College Mature Market Resource Center in Same Week 48332 1Elder Care Expert Doctor Marion Receives Accolades from Lehman College Mature Market Resource Center in Same Week 48332 2Mars mission could ease Earths energy supply crisis 8768 1Mars mission could ease Earths energy supply crisis 8768 2
Model 273 Mercury Strain Gage Plethysmograph
...he Penilab V have an exceptionally sensitive pleth...060 is similar to the Model 1061 shown below, but ...er. The Penilab V has a Doppler. These are ready...ou'll need to get started. Latex rubber cuffs do ...
Model 246 Pneumoplethysmograph
...cal performance, the ALM X'Ten is a premier, major.... , ,Its unique cross-shaped design and patent... standards needed for your surgical environment. T... the surgical field., ,A 31" column of homogen...
Medicine Products: